Navigation Links
Intravenous Access Devices Market is Expected to Reach USD 46.5 Billion Globally in 2019: Transparency Market Research
Date:12/9/2013

ALBANY, New York, December 9, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research "Intravenous Access Devices Market (Intravenous Needles, Intravenous Catheters and Intravenous Infusion Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"in 2012, the global intravenous access devices market was valued at USD 27.2 billion and is expected to grow at a CAGR of 7.8% during the forecast period of 2013 to 2019  to reach a market value of USD 46.5 billion by 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/intravenous-access-devices.html

Intravenous (IV) access devices are utilized extensively for the delivery of almost every class of drugs such as analgesics, antibiotics and antipyretics. The IV access devices include IV needles, IV catheters and IV infusion pumps. The market for IV access devices will increase tremendously at the growing rate of 7.8% during the forecast period 2013 to 2019 with the increasing incidences of various diseases such as cancer and tuberculosis (TB).Increasing geriatric population worldwide will also support the growth of this market because elderly people are highly susceptible to aforementioned diseases. In addition, shifting trend towards home healthcare will further propel the growth of infusion pumps and catheters market which will also support the overall growth of the market.

Likewise, increase in number of surgeries throughout the globe will also trigger the growth of this market since; surgeries will require these access devices for various purposes such as medication and anesthetic. For instance, in 2012around 51.4 surgeries were reported according to the Centers for Disease Control and Prevention (CDC) in the U.S. and this number is expected to increase owing to various reasons such as increase in number of accidents and lifestyle.Similarly, increase in number of vaccines will also augment the growth of this market since administration of majority of the vaccines will utilize intravenous needles.The market for intravenous catheters is expected to grow at the highest CAGR of 9% during the forecast period 2013 to 2019. This growth is attributed to its wide application areas such as it is utilized when infusion pump is implanted in the body. Similarly, price competitiveness of the catheters will also support the growth of this market tremendously.

The North American region accounted for the largest share by revenue for intravenous access devices in the year 2012 owing to large number of patient pool and geriatric population. However, Asia-Pacific is expected to show the highest growth rate of 9.4% from 2013 to 2019. This is attributed to rise in geriatric population, target diseases, increase in healthcare expenditure and improving healthcare infrastructure in the Asia-Pacific region. In addition, rise in disposable income due to economic development will also propel the growth of the market in the region since it will increase the purchasing power of individuals for various medical services such as surgeries.

Related & Recently Published Reports by Transparency Market Research

The major players operating in the market include Hospira, Inc., Becton, Dickinson and Company, CareFusion Corporation, Baxter International, B. Braun Melsungen AG and Smiths Medical.

The global intravenous access devicesmarket has been segmented as below:

Intravenous Access Devices Market, by Product Types

  • Intravenous Needles
  • Intravenous Catheters
    • Midline Peripheral Catheter
    • Central Catheters
      • Midline Peripheral Catheters
      • Centrally Inserted Catheters
  • Intravenous Infusion Pumps
    • Intravenous Insulin infusion Pumps
    • Parenteral Feeding Infusion Pumps
    • Intravenous Patient Controlled Analgesia (PCA) Infusion Pumps
    • Intravenous Syringe Infusion Pumps

Intravenous Access Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: +1-866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com/

Blog: http://www.tmrblog.com/

Blog: http://tmralbany.wordpress.com/



'/>"/>
SOURCE http://www.transparencymarketresearch.com/
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Intravenous Equipment - Global Strategic Business Report
2. 2013 China Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report
3. Systematic Review Finds Intranasal Midazolam Comparable To Intravenous Or Rectal Administration Of Diazepam For Treatment Of Acute Seizure Emergencies In Pediatric Patients
4. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
5. Global Intravenous Solutions (Parenteral Nutrition) Industry
6. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
7. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
8. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
9. Physician-Patient Alliance for Health & Safety Announces New Expert Checklist for Facilitating Safety of Hospital-Based Intravenous Patient-Controlled Analgesia Pumps
10. Catheters (Cardiovascular, Specialty, Urological, Neurovascular, and Intravenous) Market Will Reach USD 33.3 Billion Globally in 2017: Transparency Market Research
11. Roundtable of Biopharma Industry Leaders Offers Insights to Market Access Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... On Thursday, February 16, 2017, ... at the closing bell, while the Dow Jones Industrial ... Moreover, five out of nine sectors ended Thursday,s trading ... sentiment, Stock-Callers.com assessed the following Medical Appliances & Equipment ... SNN ), ABIOMED Inc. (NASDAQ: ABMD ...
(Date:2/16/2017)... 16, 2017 DaVita Inc. (NYSE: DVA ... December 31, 2016. Net income attributable to ... 2016 was $158 million, or $0.80 per share and $880 ... net income attributable to DaVita Inc. for the quarter and ... below, was $192 million, or $0.98 per share, and $789 ...
(Date:2/16/2017)...  Express Scripts (NASDAQ: ESRX ) was recognized today ... within the Health Care: Pharmacy and Other Services category. ... Most Admired Companies," said Tim Wentworth , CEO and President, ... of our 26,000 employees to make medicine more affordable and accessible ... ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each ... goals for each and every seminar, session and class she offers. ... different brainwave tools which help energize creativity, focus mental functions, enhance athletic focus ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... fall 2017 season , Trinity Health and the U.S. Soccer Foundation announced today ... program in underserved communities. Soccer for Success, the Foundation’s soccer mentoring program, teaches ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
(Date:2/17/2017)... ... 17, 2017 , ... Cancer diagnostics workflow solution provider Inspirata, ... – 22 in San Francisco. As part of the Tri-Conference expo, which is ... solution, as well as its new precision medicine platform, “Crosswalk Insight: Oncology™.” , ...
Breaking Medicine News(10 mins):